A Triple Whammy for HER2+ Breast CancerA Triple Whammy for HER2+ Breast Cancer

Dr. Lidia Schapira reports on a study showing an approach using targeted and hormonal therapies that may render chemotherapy unnecessary in a population of HER2+ breast cancer patients. Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Viewpoint Source Type: news